Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone

Clinical trial NCT06848946 · RECRUITING

Trial details

NCT number: NCT06848946
Sponsor: Glaukos Corporation
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Glaucoma, Open-angle Ocular Hypertension (OHT)Phacoemulsification Cataract Surgery

Start date: 2025-01-13
Primary completion: 2026-08-01
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.